The first initiative is the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure that COVID-19 vaccines reach those in greatest need. This initiative has the potential to benefit African countries if it succeeds in getting sufficient vaccine supplies at affordable prices that minimize debt. The proposed waiver would allow all countries globally to collaborate on the COVID-19 response, including vaccine development and distribution, without being unduly hampered by the complexity of laws and restrictions governing intellectual property.